WELCOME

Jason Gotlib, MD – AIM President

Tracy I. George, MD – AIM Secretary/ Treasurer

KEYNOTE ADDRESS:

Introduction by

Melody C. Carter, MD

Circulating Tumor Mast Cells and Other KIT-Mutated Cells in Mastocytosis

Alberto Orfao, MD, PhD

Q&A 

Moderator: Mariana Castells, MD, PhD

Cell Surface Targets of Neoplastic Cells in Advanced SM 

 Peter Valent, MD

Identification of Human Mast Cell Progenitors 

Joakim Dahlin, PhD

Classification Updates: WHO and ICC

Tracy George, MD

Bone Marrow Mast Cells In Mastocytosis: The Impact of TKIs

Anton Rets, MD, PhD

Q&A

Moderators: Tracy George, MD and Peter Valent, MD

New Biomarkers of Mastocytosis and Anaphylaxis

Gunnar Nilsson, PhD

Cytokines and Bone Disease in Mastocytosis

Tiago Rama, DMD, MD

Skin Lesions in Mastocytosis in Different Age Groups

Karin Hartmann, MD

Differential Expression of Mast Cell Mediators in Mastocytosis, MCAS, and HaT

Mariana Castells, MD, PhD

Q&A

Moderator: Mariana Castells, MD, PhD

Tryptase Monomers and Tetramers: Clinical Implications

Jonathan Lyons, MD

Non-advanced Mastocytosis

Cem Akin, MD, PhD

Advanced Mastocytosis: What is New

Deepti Radia, MBBS

Q&A

Moderator: Jason Gotlib, MD

The Approach to a Neonate with Mastocytosis

Melody Carter, MD

Depression in Mastocytosis: Impact on QOL

Jenni Nicoloro Santa Barbara, PhD

Updates in GI Manifestations of Mast Cell Disorders

Matthew Hamilton, MD

Q&A

Moderator: Melody Carter, MD

Case #1

Nathan A. Boggs, MD, PhD

Case #2

Dra. Eleonora Carla Méndez

Case #3

Lindsay Rein, MD

Moderators:

Olga Pozdnyakova, MD

Irina Maric, MD

Stephanie Lee, MD

TMS: Updates on Patient Advocacy and Research Initiatives

Judith Emmel, TMS Board Chair

Q&A

Celeste Finnerty